Glenn Phillips, PhD

Senior Director
Argenx

Poster(s):

• (208) US Commercial health plan use of corticosteroids in step therapy protocols
  Wednesday, October 29, 2025

• (241) Comparative effectiveness and economic evaluation of immunomodulatory therapies in generalized myasthenia gravis
  Wednesday, October 29, 2025